Trial Profile
A pilot, open-label study with adjunctive liraglutide in adults with mood disorders.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Sep 2017
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary)
- Indications Bipolar disorders; Major depressive disorder
- Focus Proof of concept; Therapeutic Use
- 08 Sep 2017 New trial record
- 31 Aug 2017 Priamary endpoint (Change from baseline in the overall performance on the Trail Making Test-B (TMTB)) has been met as per the results published in the European Neuropsychopharmacology
- 31 Aug 2017 Results of secondary analysis assessing effect of adjunctive liraglutide on brain structural/volumetric parameters in adults with a mood disorder published in the European Neuropsychopharmacology